We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

VFQS:QSEVodafone Qatar QSC Analysis

Data as of 2026-03-15 - not real-time

QAR 2.42

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Vodafone Qatar (VFQS) is trading at QAR 2.42, comfortably above its 20‑day SMA (2.54) and 50‑day SMA (2.53) while still below the 200‑day SMA (2.44), signalling a short‑term bullish bias within a longer‑term uptrend. The RSI sits at 37, indicating the stock is approaching oversold territory, and the MACD has turned bearish with a negative histogram, suggesting a possible short‑term correction before the broader trend resumes. The DCF‑derived fair value of QAR 2.88 and a PE of 14.2 versus the industry average of 17.8 point to an undervalued position, reinforced by a robust dividend yield of 4.95% and a payout ratio near 73% that appears sustainable given strong operating cash flow and modest leverage (debt‑to‑equity ~16%).
Volume is rising, volatility is elevated at ~26% over the past month, yet beta is near zero, indicating limited market‑wide sensitivity. The upside potential of roughly 20% to the calculated resistance level (QAR 2.68) combined with a solid balance sheet and attractive yield makes VFQS a compelling candidate for investors seeking a blend of value and income in the stable telecom sector.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near support with bearish MACD
  • Oversold RSI suggesting potential bounce
  • Rising volume supporting short‑term interest

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervalued relative to DCF and industry PE
  • Strong dividend yield and cash flow coverage
  • Bullish SMA alignment and upward price momentum

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Stable telecom sector with low beta
  • Sustainable dividend policy and modest leverage
  • Long‑run upside to fair‑value target and growth prospects

Key Metrics & Analysis

Financial Health

Revenue Growth7.20%
Profit Margin20.36%
P/E Ratio14.2
ROE13.64%
ROA6.69%
Debt/Equity15.92
P/B Ratio2.0
Op. Cash FlowQAR1.5B
Free Cash FlowQAR676.6M
Industry P/E17.8

Technical Analysis

TrendBullish
RSI37.2
SupportQAR 2.23
ResistanceQAR 2.68
MA 20QAR 2.54
MA 50QAR 2.53
MA 200QAR 2.44
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

Fair ValueQAR 2.88
Target PriceQAR 2.89
Upside/Downside19.71%
GradeUndervalued
TypeBlend
Dividend Yield4.95%

Risk Assessment

Beta-0.04
Volatility25.66%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.